The CD300f immune receptor shares many characteristics with TREM2, a key immune receptor for determining the phenotype of microglia and macrophages, and one of the main risk factor genes for the development of Alzheimer’s Disease (AD) and Nasu Hakola Disease1. This evidence concerns the gene TREM2 and Alzheimer disease.